Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0028
Research tool
Bufalin
Senolytic / Cardiac glycoside-like
Preclinical senolytic/cytotoxic research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Bufadienolide
- Primary mechanism
- Na+/K+-ATPase/cardiotonic steroid signaling
- Primary market use
- Senolytic / oncology research
Pharmacology
- Molecular weight (Da)
- 386.52
- Oral bioavailability
- Oral human data not established
- Half-life
- ~8 minutes
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Research tool
- Value-for-money score
- 1 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Potent cytotoxic/cardiotonic compound; low value due safety concerns